Antitumor efficacy of CRISPR/Cas9-engineered ICP6 mutant herpes simplex viruses in a mouse xenograft model for lung adenocarcinoma-MedSci.cn

Antitumor efficacy of CRISPR/Cas9-engineered ICP6 mutant herpes simplex viruses in a mouse xenograft model for lung adenocarcinoma

Ni, LQ; Li, Y; Wu, K; Deng, F; Wang, HL; Ning, YJ

Wang, HL; Ning, YJ (通讯作者)，Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China.

JOURNAL OF MEDICAL VIROLOGY, 2022; 94 (12): 6000

科室
- - 订阅+
  - 更多科室
工具
服务